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Abstract
Background: Diisopropyl fluorophosphate (DFP) is a serine protease inhibitor that is widely used as an inhibitor of
endogenous proteases in in vitro neutrophil studies. Its effects on neutrophil function are unclear. We sought to
determine the biological effects of DFP on human neutrophil apoptosis and oxidative burst.
Methods: We isolated neutrophils from healthy volunteers, incubated them with DFP (2.5 mM), and evaluated
neutrophil elastase (NE) activity, neutrophil degranulation, apoptosis as reflected in hypodiploid DNA formation and
exteriorization of phosphatidylserine (PS), processing and activity of caspases-3 and -8, oxidative burst activity and
hydrogen peroxide release.
Results: Consistent with its activity as a serine protease inhibitor, DFP significantly inhibited NE activity but not the
degranulation of azurophilic granules. DFP inhibited constitutive neutrophil apoptosis as reflected in DNA
fragmentation, and the processing and activity of caspases-3 and -8. DFP also inhibited priming of neutrophils for
oxidative burst activity and hydrogen peroxide release. However, DFP enhanced the exteriorization of PS in a dose-
dependent manner.
Conclusion: We conclude that DFP exerts significant effects on neutrophil inflammatory function that may
confound the interpretation of studies that use it for its antiprotease activity. We further conclude that endogenous
proteases play a role in the biology of constitutive neutrophil apoptosis.
Background
Diisopropyl fluorophosphate (DFP) is an irreversible ser-
ine protease inhibitor. Its hydrophobic nature and low
molecular weight allow it to permeate intact cells and
intracellular granules to prevent proteolysis before cellu-
lar barriers are disrupted by homogenization or deter-
gent [1]. Since neutrophil granules contain potent
endogenous proteases, DFP is commonly used in neu-
trophil studies to prevent degradation of proteins [1]. In
addition to its use as a protease inhibitor, the radioactive
form of DFP has been used to label granulocytes to
study neutrophil kinetics in humans [2].
Neutrophil serine proteases - cathepsin G, neutrophil
elastase (NE) and proteinase 3 are enzymes that are
stored in azurophilic granules and are important in
intracellular microbial killing [3]. NE has many physiolo-
gical roles, including the regulation of neutrophil che-
motaxis [4], adhesion [5] and migration [6]. However,
excessive NE can result in cell and tissue injury by com-
promising the integrity of endothelial vascular barrier
and promoting microvascular injury, resulting in
increased permeability and interstitial edema [7,8]. NE
can also induce the expression and release of IL-8 - a
potent neutrophil chemoattractant that promotes neu-
trophil recruitment [9,10], release of granular enzymes
and respiratory burst activity [11].
Studies of the biological effects of DFP on cell types
other than neutrophils are abundant. For example, it has
been previously shown that DFP can block T cell recep-
tor-triggered apoptosis in murine T cell hybridomas and
activated peripheral T cells [12]; ricin-induced apoptosis
of Madin-Darby canine kidney cells [13]; and tumour
necrosis factor-induced apoptosis of a myeloid leukemic
cell line [14]. Despite its widespread use in neutrophil
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not fully understood or studied.
The reported biological effects of DFP on neutrophils
are conflicting. Some studies found that DFP has no
effect on neutrophil oxidant production, metalloprotei-
nase release, migration [15,16] or phagocytosis [1].
Other studies, however, have reported that DFP
decreases the rate of hydrogen peroxide production by
neutrophils following stimulation with phorbol myristate
acetate (PMA) [17]; suppresses oxygen radical formation
from guinea pig neutrophils stimulated with comple-
ment-treated zymosan [18]; and suppresses neutrophil
phagocytosis [19] and migration [20].
We sought to investigate the effects of DFP on neu-
trophil functions at a dose (2.5 mM) commonly used in
experimental studies [20], specifically focusing on apop-
tosis and priming of oxidative burst activity. We report
differential effects of DFP on neutrophil apoptosis and
priming of oxidative burst activity, reflected in suppres-
sion of constitutive apoptosis and the priming of oxida-
tive burst function.
Methods
Neutrophil Isolation and Culture
We obtained up to 60 mL of whole blood from healthy
volunteers, drawing blood into heparinized tubes. We
isolated neutrophils by dextran sedimentation and cen-
trifugation through a discontinuous Ficoll gradient as
previously described [21]; cell populations were consis-
tently >95% neutrophils, and viability as assessed by try-
pan blue exclusion routinely exceeded 95%. Neutrophils
were resuspended in polypropylene tubes at a concen-
tration of 1 × 10
6 cells/mL in supplemented DMEM
with 10% fetal bovine serum and 1% penicillin/strepto-
mycin solution (Gibco/BRL).
Reagents
Antibodies (dilutions; suppliers) used for these studies
were murine monoclonal anti-caspase-8 (1:500; Calbio-
chem), rabbit polyclonal anti-cleaved-caspase-3 (1:500;
Calbiochem), murine monoclonal anti-beta-actin
(1:4000; Sigma), anti-mouse IgG HRP-conjugated
(1:4000; GE Health Care) and anti-rabbit IgG HRP-con-
jugated (1:4000; GE Health Care).
Diisopropyl fluorophosphate (DFP), a serine protease
inhibitor, was purchased from EMD Biosciences. Lipo-
polysaccharide (LPS) (E. coli Serotype 0111:B4) was
purchased from Sigma.
Neutrophil Elastase Activity Assay
We measured NE activity using a fluorimetric substrate
(MeOSuc-Ala-Ala-Pro-Val AMC, Biomol, USA). Briefly,
2×1 0
7 cells were lysed in 400 μL of chilled lysis buffer
(10 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1%
Triton X-100, 10 mM NaF, 1 mM PMSF, 1 mM
Na3VO4,1 0μg/mL leupeptin, 10 μg/mL aprotinin).
After measuring protein concentration, 50 μL of cell
lysate supernatant was incubated with sample buffer in
a 96-well plate at room temperature for 1 hour. The
plate was washed four times with sample buffer and 50
μL of a specific substrate for NE was added to the 96-
well plate. The plate was then incubated for 4 hours at
37°C. Fluorescence was measured using a fluorimetric
plate reader (Fluoroskan) at an excitation wavelength of
355 nm and an emission wavelength 460 nm. Data were
analyzed using Ascent Software. NE activity was
expressed as arbitrary fluorimetric units (AFU).
Neutrophil Degranulation Study
We measured neutrophil degranulation by measuring
peroxidase release as described [22]. We plated 1.5 ×
10
5 neutrophils in triplicate in a 96 well tissue culture
plate (Sarstedt Microtest Plate). We added 20 μL of con-
trol buffer with or without DFP (2.5 mM), then incu-
bated cells at 37°C in a humidified incubator for 1 hour.
At the end of the incubation period, the peroxidase
reaction was started by adding 70 μLo f2 . 8m MT M B
in PBS and 60 μL of 1 mM hydrogen peroxide. After 1
minute of incubation at room temperature, the reaction
was blocked with 50 μL of stop solution (500 μLo f1 0
mM sodium azide in 4 N of acetic acid).
Oxidation of TMB was then monitored at 620 nm using
a microplate reader (Multiskan Plate Reader, Labsystems).
Data were analyzed using Ascent software. The peroxidase
activity released in the extracellular environment was
expressed as a percentage of the total peroxidase activity
of 1.5 × 10
5 neutrophils. The total peroxidase activity
(100%) was extrapolated from the linear part of calibration
curves prepared by assaying the peroxidase activity of dif-
ferent numbers of neutrophils in the presence of 0.02%
CTAP (cetyltrimethylammonium bromide).
Quantification of Constitutive Apoptosis
We measured percentage of neutrophil apoptosis by
flow cytometry, quantifying the amount of hypodiploid
DNA formation as the uptake of propidium iodide in
Triton-X-100 permeabilized cells as previously described
[21,23]. After 20 hours of cell culture incubation, Tri-
ton-X-100 permeabilized neutrophils were incubated
with propidium iodide (50 μg/mL) and analyzed using a
BD FACS CANTO Flow Cytometer. Data were analyzed
using BD FACS DIVA software. A minimum of 10 000
events were collected and analyzed at excitation wave-
length of 488 nm and emission wavelength of 690 nm.
Western Blot Studies
We lysed 3 × 10
6 neutrophils in lysis buffer (10 mM
T r i s ,p H7 . 4 ,1 5 0m MN a C l ,5m ME D T A ,1 %T r i t o n
Tsang et al. Journal of Inflammation 2010, 7:32
http://www.journal-inflammation.com/content/7/1/32
Page 2 of 9X-100, 10 mM NaF, 1 mM PMSF, 1 mM Na3VO4,1 0
μg/mL leupeptin, 10 μg/mL aprotinin). Cell lysates were
run on a 12% SDS-PAGE gel, transferred to nitrocellu-
lose (Amersham Pharmacia Biotech), and probed with
the appropriate primary antibody. Bands were detected
with an HRP-conjugated secondary antibody at a dilu-
tion of 1:4000 using the ECL Western blotting detection
system (Amersham Pharmacia Biotech). Blots were
stripped and reprobed with a monoclonal antibody to
beta-actin at a 1:4000 dilution, to confirm equal loading
of proteins.
Caspase-3 Activity Assay
We measured caspase-3 activity using a fluorimetric
substrate (Ac-DEVD-AMC, Biomol, USA). We lysed 2 ×
10
7 cells in 400 μL of chilled lysis buffer (10 mM Tris,
pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100,
1 0m MN a F ,1m MP M S F ,1m MN a 3VO4,1 0μg/mL
leupeptin, 10 μg/mL aprotinin). After measuring protein
concentration, 25 μL of cell lysate supernatant was incu-
bated with 50 μL of a specific substrate (Ac-DEVD-
AMC) for caspase-3 in a 96-well plate. Fluorescence was
measured using a fluorimetric plate reader (Fluoroskan)
at an excitation wavelength of 355 nm and an emission
wavelength of 460 nm. Data were analyzed using Ascent
Software. Caspase-3 activity was expressed as arbitrary
fluorimetric units (AFU).
Caspase-8 Activity Assay
We measured caspase-8 activi t yu s i n gac o l o r i m e t r i c
substrate (IETD-pNA, BioVision CA USA). We lysed
2×1 0
7 cells in 400 μL of chilled lysis buffer (10 mM
T r i s ,p H7 . 4 ,1 5 0m MN a C l ,5m ME D T A ,1 %T r i t o n
X - 1 0 0 ,1 0m MN a F ,1m MP M S F ,1m MN a 3VU4,
10 μg/mL leupeptin, 10 μg/mL aprotinin). After measur-
ing protein concentration, 75 μL of cell lysate superna-
tant was incubated with 5-7.5 μL of a specific substrate
(IETD-pNA) for caspase-8 in a 96-well plate. Plates
were incubated at 37°C for 1 hour and color development
measured using a colorimetric plate reader (LabSystems
Multiskan; Ascent Software) at 405 nm; caspase-8 activity
was expressed as absorbance at 405 nm.
Quantification of Exteriorization of Phosphatidylserine
We measured early events in apoptosis by flow cytome-
try, quantifying the binding of Annexin V to exteriorized
PS [24]. After 5 hours of cell culture, neutrophils were
incubated with Annexin V conjugated to the fluoro-
chrome FITC (R&D Systems) and analyzed using a BD
FACS CANTO Flow Cytometer with BD FACS DIVA
software. A minimum of 10 000 events were collected
and analyzed at excitation wavelength of 488 nm and
emission wavelength of 518 nm.
Quantification of Oxidative Burst Activity
We measured oxidative burst activity by flow cytometry,
quantifying the conversion of dihydrorhodamine 123
(DHR) to rhodamine 123 as previously described [25].
Neutrophils were incubated with 1 μM of DHR (Invitro-
gen) at 37°C for 5 minutes followed by incubation with
10
-7 M N-Formyl-Met-Leu-Phe (fMLP) for 10 minutes
at 37°C. A minimum of 10 000 events were collected
and analyzed at excitation wavelength of 488 nm and
emission wavelength of 518 nm.
Quantification of Hydrogen Peroxide Production
We measured hydrogen peroxide production using the
Amplex Red Hydrogen Peroxide Kit (Invitrogen) follow-
ing the manufacturer’s instructions. Briefly, after incu-
bating neutrophils with appropriate stimuli, cells were
washed, then resuspended in Krebs-Ringer Phosphate
(KRPG) buffer. We incubated 2 × 10
4 cells with Amplex
Red reaction mixture with 10
-7 M of fMLP at 37°C for
3 hours. Fluorescence was measured using a fluorimetric
plate reader (Fluoroskan) at an excitation wavelength of
544 nm and an emission wavelength of 590 nm. Data
were analyzed using Ascent Software. Hydrogen per-
oxide production was calibrated against a standard
curve and was represented in μM.
Statistical Analysis
Results are reported as the mean ± standard deviation,
unless otherwise noted. The paired Student’stt e s tw a s
used to compare continuous variables. The alpha level
for statistical significance was set at p < 0.05. Analyses
were performed using SPSS Statistics 15.0.
Results
DFP suppresses neutrophil elastase activity but not
neutrophil degranulation
DFP is an irreversible serine protease inhibitor. We first
sought to confirm the effect of DFP on neutrophil endo-
genous serine protease activity by quantifying neutrophil
elastase (NE) activity in neutrophils that had been
exposed to DFP (2.5 mM) for 5 hours. DFP significantly
inhibited neutrophil NE activity to levels less than 20%
of those of control cells (Figure 1A). In contrast, LPS (1
μg/mL) - a stimulus known to inhibit constitutive neu-
trophil apoptosis [14] had no effect on NE activity (Fig-
ure 1A). The inhibition of NE activity by DFP was dose
dependent (Figure 1B). NE is stored in neutrophil azuro-
philic granules. Since reduced NE activity might reflect
impaired degranulation, we sought to determine
whether DFP suppresses degranulation of neutrophils by
measuring peroxidase release in neutrophils that were
treated with or without DFP (2.5 mM) for 1 hour. DFP
did not inhibit neutrophil degranulation (Figure 1C).
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measured by hypodiploid DNA formation
Quiescent neutrophils are constitutively apoptotic;
inflammatory stimuli such as LPS inhibit neutrophil
apoptosis. Neutrophils were cultured with or without
LPS or DFP for 20 hours and apoptosis quantified as
the uptake of propidium iodide. LPS (1 μg/mL) signifi-
cantly inhibited hypodiploid DNA formation compared
to control neutrophils. DFP (2.5 mM) caused signifi-
cantly greater inhibition (Figure 2A &2B), in a dose-
dependent manner (Figure 2C). We confirmed that
isopropanol, the vehicle in which DFP is dissolved in,
did not inhibit neutrophil hypodiploid DNA formation
(data not shown). Similar results were obtained
when neutrophils were cultured in serum free media
(Figure 2D).
Figure 1 Effect of DFP on NE activity and neutrophil degranulation. Human neutrophils were incubated in medium alone (Control), with
LPS (1 μg/mL) or with DFP at increasing doses (25 nM, 2.5 μM, 250 μM, and 2.5 mM) for 5 hours. Cells were then lyzed and NE activity was
measured at an excitation wavelength of 360 nm and emission wavelength of 460 nm; results are represented as arbitrary fluorescence units. A.
NE activity of neutrophils treated with or without LPS or DFP (2.5 mM). Data represent the mean ± SD of 9 separate experiments. *P = 0.010. B.
NE activity of neutrophils treated with increasing doses of DFP; results are from a single experiment. C. Human neutrophils were incubated with
or without DFP (2.5 mM) for 1 hour and peroxidase release was measured as described in Materials and Methods. Peroxidase release was
expressed as percentage of the total peroxidase activity of 150 000 neutrophils treated with 0.02% CTAB. Data represent mean ± SD of 4
separate experiments. P = NS.
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activity
Caspases are synthesized as pro-enzymes that are
cleaved at conserved tetra-or pentapeptide amino acid
sequences adjacent to aspartic acid residues to form cat-
alytically active enzymes. Spontaneous neutrophil apop-
tosis can be initiated via either the extrinsic pathway as
a consequence of caspase-8 activation following death
receptor engagement [26] or the intrinsic pathway as a
consequence of loss of mitochondrial transmembrane
potential with activation of caspase-9 [27]. Both path-
ways result in the activation of the downstream effector,
caspase-3. Since caspase activation precedes DNA degra-
dation, we studied the effects of DFP on the processing
of caspases-3 and -8 at 5 hours. Consistent with an
inhibitory effect on apoptosis, pro-caspase-8 was
Figure 2 Effect of DFP on neutrophil constitutive apoptosis. Human neutrophils were incubated alone (Control), with LPS (1 μg/mL) or with
increasing doses of DFP for 20 hours. Cells were permeabilized with Triton X-100 and then stained with propidium iodide (50 μg/mL). A. Mean
fluorescence values are shown for a minimum of 10 000 cells for each condition and are representative of 3 determinations from 13 separate
experiments. B. Rate of apoptosis (hypodiploid DNA) of neutrophils treated with or without LPS or DFP (2.5 mM) are represented. Data represent
mean ± SD of 15 separate experiments. *P < 0.05. C. Rate of apoptosis (hypodiploid DNA) of neutrophils treated with or without increasing
doses of DFP. Data represent mean ± SD of 2 to 8 separate experiments. D. Rate of apoptosis (hypodiploid DNA) of neutrophils treated with LPS
or DFP (2.5 mM) from control cells cultured in serum free medium. Results are mean ± SD of 2 separate experiments.
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12kDa form of caspase-3 was significantly reduced in
DFP treated neutrophils (Figure 3B). Moreover DFP
inhibited both caspase-8 activity (Figure 3C), and cas-
pase-3 activity (Figure 3D). The inhibition of caspase-3
activity by DFP was significantly greater than that
induced by exposure to LPS (p <0.05).
DFP significantly increases exteriorization of
phosphatidylserine in neutrophils
We next sought to determine the effects of DFP on a
separate early event in apoptosis, the exteriorization of
phosphatidylserine (PS) on the cell membrane. Contrary
to the effects of DFP on hypodiploid DNA formation,
culture of neutrophils with DFP (2.5 mM) for 5 hours
significantly increased the amount of exteriorized PS
as demonstrated by increased binding of Annexin V
(Figure 4A). Increased exteriorization of PS was dose-
dependent (Figure 4B). In contrast, culture of neutro-
phils with LPS (1 μg/mL) for 5 hours suppressed the
exteriorization of PS (Figure 4A). Thus DFP exerts
differential effects on early and late events in the pro-
gression of apoptosis. Isopropanol had no effect on the
exteriorization of phosphatidylserine (data not shown).
DFP significantly suppresses neutrophil priming for
oxidative burst activity and production of hydrogen
peroxide (H2O2)
Stimuli such as LPS that delay apoptosis typically prime
neutrophils for enhanced oxidative burst activity in
response to stimuli such as fMLP [28]. We therefore
assessed the effects of DFP on neutrophil oxidative
burst activity as measured by the conversion of DHR
123 to rhodamine 123. Neutrophils were incubated with
or without LPS (1 μg/mL) or DFP (2.5 mM) for 2 hours.
Cells were then incubated with 1 μ M of DHR, with 10
-7
M of fMLP. When compared to neutrophils which were
cultured alone, LPS-primed neutrophils showed a signif-
icant increase in oxidative burst activity (Figure 5A
&5B). In contrast, neutrophils that were cultured with
DFP demonstrated a significant decrease in oxidative
burst activity (Figure 5A &5B). Similar results were
obtained when DFP was washed from the cells before
DHR was added (data not shown). Isopropanol had no
effect on oxidative burst activity (data not shown).
Whereas LPS stimulated neutrophil production of
hydrogen peroxide, DFP (2.5 mM) significantly inhibited
fMLP-induced production of hydrogen peroxide (Figure
5C); isopropanol alone was without effect.
Figure 3 Effect of DFP on processing of pro-caspases-3 and -8 and caspases-3 and -8 activity. Human neutrophils were incubated alone
(Control) or with DFP 2.5 mM for 5 hours. Cells were then lyzed and lysates were separated on 12% SDS-PAGE gel and specific antibodies were
used to evaluate the pattern of caspase-8 (A) and caspase-3 (B) processing. Blot is representative of 3 separate experiments. C. Human
neutrophils were incubated alone (Control), with LPS (1 μg/mL) or with DFP (2.5 mM) for 5 hours. Cells were then lyzed. Caspase-8 and caspase-
3 activities were measured using specific colorimetric and fluorimetric substrates respectively. Caspase-8 (C) activity is represented as absorbance
at 405 nm & caspase-3 (D) activity is represented as fluorescence units at excitation wavelength of 360 nm and emission wavelength of 460 nm.
Data represent mean ± SD of 4 separate experiments. *P = 0.243 for caspase-8; *P = 0.02 for caspase-3.
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Page 6 of 9Figure 4 Effect of DFP on exteriorization of phosphatidylserine quantified as the uptake of Annexin V. Human neutrophils were
incubated alone (Control), with LPS (1 μg/mL) or with increasing doses of DFP for 5 hours. Cells were centrifuged and incubated with FITC-
conjugated Annexin. Phosphatidylserine exteriorization was detected as mean channel fluorescence at an excitation wavelength of 388 nm and
emission wavelength of 520 nm. A. Phosphatidylserine exteriorization of neutrophils treated with or without LPS or DFP (2.5 mM). Data represent
mean ± SD of 4 separate experiments. *P = 0.349 versus controls, p < 0.001 versus LPS. B. Phosphatidylserine exteriorization of neutrophils
treated with or without various doses of DFP. Data represent mean ± SD of 2 to 3 separate experiments.
Figure 5 Effect of DFP on PMN oxidative burst activity and hydrogen peroxide production. Human neutrophils were incubated alone
(Control), with LPS (1 μg/mL) or with DFP (2.5 mM) for 2 hours. Cells were then incubated with 1 μM of DHR followed by incubation with 10
-7
M fMLP. Cells were analyzed by flow cytometry to detect the conversion of DHR 123 to rhodamine 123. A. Mean fluorescence values are shown
for a minimum of 10 000 cells for each condition and are representative of 9 separate experiments. B. Oxidative burst activity of neutrophils
treated with or without LPS or DFP (2.5 mM). Data represent mean ± SD of 9 separate experiments. *P < 0.002. C. Neutrophils were incubated
alone (control), with LPS (1 μg/mL) or with DFP (2.5 mM) for 0, 1 and 2 hours. 2 × 10
4 cells were incubated with Amplex Red reaction mixture
and 10
-7 M fMLP. Hydrogen peroxide production was measured using fluorimetric reader, and expressed in μM. Data represent mean ± SD of 7
separate experiments. *P = 0.015
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Neutrophils are potent cellular effectors of the early
innate response to infection and tissue injury, and their
unique biology reflects this critical role. Neutrophils con-
tain significant amounts of proteolytic enzymes (neutro-
phil elastase, cathepsin G and proteinase 3) stored in
azurophilic granules [29]; have the capacity to generate
reactive oxygen species [30]; express receptors for Fc
component of immunoglobulin and have very short life-
span in vivo and in vitro as a consequence of the activa-
tion of a constitutive apoptotic program following their
release from the bone marrow [31]. Because of their
intracellular stores of potent proteolytic enzymes, cell
culture studies routinely employ inhibitors to prevent
artefactual degradation of intracellular proteins. The
effects of these inhibitors are poorly characterized.
DFP is an irreversible serine protease inhibitor that
permeates intact cells and intracellular granules to pre-
vent proteolysis before cellular barriers are disrupted by
homogenization or detergents [1]. It is widely used in
experiments that involve neutrophils. Here, we con-
firmed that DFP neutralizes endogenous protease activ-
ity, and specifically that of neutrophil elastase. However
we also showed that this inhibition alters key neutrophil
functions, including the capacity to undergo sponta-
neous programmed cell death and to induce an oxida-
tive burst in response to formylated peptides.
DFP significantly suppresses neutrophil constitutive
apoptosis, and to a greater extent than LPS - a well-
known inhibitor of neutrophil apoptosis. This inhibition
is associated with reduced processing of pro-caspases-3
and -8, and suppression of the activity of caspases-3 and
-8, resulting in reduced generation of hypodiploid DNA.
Exteriorization of PS serves as recognition (“eat-me”)
signal for the phagocytosis of apoptotic cells [32]. Exter-
iorization of PS is thought to occur downstream of cas-
pase activation in some cell types [33] and is enhanced
by reactive oxygen species [34]. We found that despite
the inhibition of hypodiploid DNA formation, and cas-
pase activity, DFP enhanced the exteriorization of PS in
a dose-dependent fashion, suggesting that exteriorization
of PS can occur independently of the enzymatic changes
of apoptosis. Balasubramanian et al showed that PS
exteriorization can occur through a mechanism that is
independent of cytochrome c release, caspase activation,
and DNA fragmentation [35]. DFP may directly influ-
ence the activity of flippases and floppases or lipid
scramblase, increasing the exteriorization of PS.
We also demonstrated that DFP has a significant inhi-
bitory effect on the priming of neutrophils to respond
to fMLP and release reactive oxygen species. This inhi-
bition was evidenced as reduced conversion of DHR 123
to rhodamine 123 and reduced release of hydrogen
peroxide. These results raise the possibility that serine
proteases, in addition to their direct role in the intracel-
lular killing of microorganisms, may also participate in
indirect killing by enhancing the neutrophils’ ability to
respond to stimuli, such as the bacterial tripeptide fMLP
with an increased generation of reactive oxygen species.
Of note, DFP did not suppress oxidative burst signifi-
cantly in the absence of fMLP.
The demonstration of the modulation of events in the
evolution of apoptosis by DFP underscores the potential
roles of serine proteases in the regulation of apoptosis.
Our results further suggest that neutrophil serine pro-
teases enhance the priming of neutrophils for oxidative
burst activity.
Conclusion
On the one hand, our results suggest additional roles for
serine proteases in the orchestration of an innate
immune response through their effects in enhancing
neutrophil priming for oxidative burst and apoptosis.
On the other hand, they underscore a potential draw-
back in using DFP in neutrophil studies to prevent
proteolysis and to perform granulocyte kinetic studies
in vivo, and suggest that caution must be taken in inter-
preting the results of studies in which DFP has been
used for its anti-protease activity.
Acknowledgements
The authors would like to thank Professor Andras Kapus and Dr. Katalin
Szaszi for their valuable comments during the preparation of this
manuscript.
This study was supported by a grant from Canadian Institute of Health
Research #MOP 62908.
Author details
1Interdepartmental Division of Critical Care, University of Toronto, Toronto,
Canada.
2Departments of Critical Care Medicine and Surgery, Saint Michael’s
Hospital, Room 4-007, Bond Wing, 30 Bond Street, Toronto, Ontario, M5B
1W8, Canada.
3Department of Critical Care Medicine, Sunnybrook Health
Sciences Centre, 2075 Bayview Avenue, Room D112, Toronto, Ontario, M4N
3M5, Canada.
Authors’ contributions
JLYT designed and planned all experiments, performed most of the
experiments, analyzed and interpreted all the data, prepared and revised the
manuscript. JCP performed some of the experiments. JCM obtained funding,
participated in analysis and interpretation of the data, and revised the
manuscript. All the authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 November 2009 Accepted: 7 July 2010
Published: 7 July 2010
References
1. Amrein PC, Stossel TP: Prevention of degradation of human
polymorphonuclear leukocyte proteins by diisopropylfluoropho sphate.
Blood 1980, 56:442-447.
2. Athens JW, Haab OP, Raab SO, Mauer AM, Ashenbrucker H, Cartwright GE,
Wintrobe MM: Leukokinetic studies. IV. The total blood, circulating and
Tsang et al. Journal of Inflammation 2010, 7:32
http://www.journal-inflammation.com/content/7/1/32
Page 8 of 9marginal granulocyte pools and the granulocyte turnover rate in normal
subjects. J Clin Invest 1961, 40:989-995.
3. Belaaouaj A, Kim KS, Shapiro SD: Degradation of outer membrane protein
A in Escherichia coli killing by neutrophil elastase. Science 2000,
289:1185-1188.
4. DiMartino SJ, Shah AB, Trujillo G, Kew RR: Elastase controls the binding of
the vitamin D-binding protein (Gc-globulin) to neutrophils: a potential
role in the regulation of C5a co-chemotactic activity. J Immunol 2001,
166:2688-2694.
5. Cai TQ, Wright SD: Human leukocyte elastase is an endogenous ligand
for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and
modulates polymorphonuclear leukocyte adhesion. J Exp Med 1996,
184:1213-1223.
6. Kaynar AM, Houghton AM, Lum EH, Pitt BR, Shapiro SD: Neutrophil
elastase is needed for neutrophil emigration into lungs in ventilator-
induced lung injury. Am J Respir Cell Mol Biol 2008, 39:53-60.
7. Carden D, Xiao F, Moak C, Willis BH, Robinson-Jackson S, Alexander S:
Neutrophil elastase promotes lung microvascular injury and proteolysis
of endothelial cadherins. Am J Physiol 1998, 275:H385-392.
8. Moraes TJ, Chow CW, Downey GP: Proteases and lung injury. Crit Care
Med 2003, 31:S189-194.
9. Chen HC, Lin HC, Liu CY, Wang CH, Hwang T, Huang TT, Lin CH, Kuo HP:
Neutrophil elastase induces IL-8 synthesis by lung epithelial cells via the
mitogen-activated protein kinase pathway. J Biomed Sci 2004, 11:49-58.
10. Kuwahara I, Lillehoj EP, Lu W, Singh IS, Isohama Y, Miyata T, Kim KC:
Neutrophil elastase induces IL-8 gene transcription and protein release
through p38/NF-{kappa}B activation via EGFR transactivation in a lung
epithelial cell line. Am J Physiol Lung Cell Mol Physiol 2006, 291:L407-416.
11. Baggiolini M, Clark-Lewis I: Interleukin-8, a chemotactic and inflammatory
cytokine. FEBS Lett 1992, 307:97-101.
12. Sarin A, Adams DH, Henkart PA: Protease inhibitors selectively block T cell
receptor-triggered programmed cell death in a murine T cell hybridoma
and activated peripheral T cells. J Exp Med 1993, 178:1693-1700.
13. Oda T, Komatsu N, Muramatsu T: Diisopropylfluorophosphate (DFP)
inhibits ricin-induced apoptosis of MDCK cells. Biosci Biotechnol Biochem
1998, 62:325-333.
14. Higuchi M, Singh S, Chan H, Aggarwal BB: Protease inhibitors differentially
regulate tumor necrosis factor-induced apoptosis, nuclear factor-kappa
B activation, cytotoxicity, and differentiation. Blood 1995, 86:2248-2256.
15. Kubes P, Smith R, Grisham MD, Granger DN: Neutrophil-mediated
proteolysis. Differential roles for cathepsin G and elastase. Inflammation
1993, 17:321-332.
16. Rice WG, Weiss SJ: Regulation of proteolysis at the neutrophil-substrate
interface by secretory leukoprotease inhibitor. Science 1990, 249:178-181.
17. Goldstein BD, Witz G, Amoruso M, Troll W: Protease inhibitors antagonize
the activation of polymorphonuclear leukocyte oxygen consumption.
Biochem Biophys Res Commun 1979, 88:854-860.
18. Yukishige K, Tamoto K, Koyama J: Inhibitory effect of di-isopropyl
fluorophosphate on activation of an O-2-forming enzyme of
polymorphonuclear leukocytes with C3b-zymosan. FEBS Lett 1981,
124:19-22.
19. Musson RA, Becker EL: The role of an activatable esterase in immune-
dependent phagocytosis by human neutrophils. J Immunol 1977,
118:1354-1365.
20. Ginzberg HH, Cherapanov V, Dong Q, Cantin A, McCulloch CA, Shannon PT,
Downey GP: Neutrophil-mediated epithelial injury during transmigration:
role of elastase. Am J Physiol Gastrointest Liver Physiol 2001, 281:G705-717.
21. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC: Pre-B cell
colony-enhancing factor inhibits neutrophil apoptosis in experimental
inflammation and clinical sepsis. J Clin Invest 2004, 113:1318-1327.
22. Menegazzi R, Zabucchi G, Knowles A, Cramer R, Patriarca P: A new, one-
step assay on whole cell suspensions for peroxidase secretion by
human neutrophils and eosinophils. J Leukoc Biol 1992, 52:619-624.
23. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and
simple method for measuring thymocyte apoptosis by propidium iodide
staining and flow cytometry. J Immunol Methods 1991, 139:271-279.
24. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van
Oers MH: Annexin V for flow cytometric detection of phosphatidylserine
expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420.
25. Richardson MP, Ayliffe MJ, Helbert M, Davies EG: A simple flow cytometry
assay using dihydrorhodamine for the measurement of the neutrophil
respiratory burst in whole blood: comparison with the quantitative
nitrobluetetrazolium test. J Immunol Methods 1998, 219:187-193.
26. Jia SH, Parodo J, Kapus A, Rotstein OD, Marshall JC: Dynamic regulation of
neutrophil survival through tyrosine phosphorylation or
dephosphorylation of caspase-8. J Biol Chem 2008, 283:5402-5413.
27. Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD, Marshall JC: Delayed
neutrophil apoptosis in sepsis is associated with maintenance of
mitochondrial transmembrane potential and reduced caspase-9 activity.
Crit Care Med 2004, 32:1460-1469.
28. DeLeo FR, Renee J, McCormick S, Nakamura M, Apicella M, Weiss JP,
Nauseef WM: Neutrophils exposed to bacterial lipopolysaccharide
upregulate NADPH oxidase assembly. J Clin Invest 1998, 101:455-463.
29. Moraes TJ, Zurawska JH, Downey GP: Neutrophil granule contents in the
pathogenesis of lung injury. Curr Opin Hematol 2006, 13:21-27.
30. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE: Free radicals and
phagocytic cells. Faseb J 1995, 9:200-209.
31. Akgul C, Moulding DA, Edwards SW: Molecular control of neutrophil
apoptosis. FEBS Lett 2001, 487:318-322.
32. Savill J, Fadok V: Corpse clearance defines the meaning of cell death.
Nature 2000, 407:784-788.
33. Martin SJ, Finucane DM, Amarante-Mendes GP, O’Brien GA, Green DR:
Phosphatidylserine externalization during CD95-induced apoptosis of
cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem
1996, 271:28753-28756.
34. Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenstrom-Magnusson C, Liu SX,
Serinkan FB, Arroyo A, Chandra J, Orrenius S, Fadeel B: A role for oxidative
stress in apoptosis: oxidation and externalization of phosphatidylserine
is required for macrophage clearance of cells undergoing Fas-mediated
apoptosis. J Immunol 2002, 169:487-499.
35. Balasubramanian K, Mirnikjoo B, Schroit AJ: Regulated externalization of
phosphatidylserine at the cell surface: implications for apoptosis. J Biol
Chem 2007, 282:18357-18364.
doi:10.1186/1476-9255-7-32
Cite this article as: Tsang et al.: Regulation of apoptosis and priming of
neutrophil oxidative burst by diisopropyl fluorophosphate. Journal of
Inflammation 2010 7:32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tsang et al. Journal of Inflammation 2010, 7:32
http://www.journal-inflammation.com/content/7/1/32
Page 9 of 9